Home  |  Contact

UniProtKB/Swiss-Prot Q14118: Variant p.Asp111Asn

Dystroglycan
Gene: DAG1
Variant information

Variant position:  111
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  LP/P [Disclaimer]
The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change:  From Aspartate (D) to Asparagine (N) at position 111 (D111N, p.Asp111Asn).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from medium size and acidic (D) to medium size and polar (N)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  1
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description:  In MDDGC9; does not affect dystroglycan expression; impairs alpha-dystroglycan glycosylation.
Any additional useful information about the variant.

Other resources:  
Links to websites of interest for the variant.



Sequence information

Variant position:  111
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  895
The length of the canonical sequence.

Location on the sequence:   GDIIKVSAAGKEALPSWLHW  D SQSHTLEGLPLDTDKGVHYI
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         GDIIKVSAAGKEALPSWLHWDSQSHTLEGLPLDTDKGVHYI

                              GELVKVSAVGKEVLPSWLHWDPQSHTLEGLPLDTDKGVHYI

Mouse                         GEIIKVSAAGKEALPSWLHWDPHSHILEGLPLDTDKGVHYI

Pig                           GEIIKVSAAGKEALPSWLHWDPQSHTLEGLPLDTDKGVHYI

Bovine                        GEVIKVSAAGKEALPSWLHWDPQSHTLEGLPLDTDKGVHYI

Rabbit                        GEVIKVSTAGKEVLPSWLHWDPQSHTLEGLPLDTDKGVHYI

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 30 – 653 Alpha-dystroglycan
Region 30 – 408 Required for laminin recognition
Beta strand 108 – 111


Literature citations

DAG1 mutations associated with asymptomatic hyperCKemia and hypoglycosylation of alpha-dystroglycan.
Dong M.; Noguchi S.; Endo Y.; Hayashi Y.K.; Yoshida S.; Nonaka I.; Nishino I.;
Neurology 84:273-279(2015)
Cited for: INVOLVEMENT IN MDDGC9; VARIANTS MDDGC9 ILE-74 AND ASN-111; CHARACTERIZATION OF VARIANTS MDDGC9 ILE-74 AND ASN-111;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.